-
Q2 EPS Estimate for TScan Therapeutics Lowered by Analyst
Source: Buzz FX / 10 Mar 2025 01:56:16 America/New_York
Q2 EPS Estimate for TScan Therapeutics Lowered by Analyst Written by MarketBeat March 10, 2025 Share Link copied to clipboard. Remove Ads TScan Therapeutics, Inc. ( NASDAQ:TCRX - Free Report ) - Investment analysts at HC Wainwright dropped
Read more...